Shigeru Yoshizawa

1.7k total citations
37 papers, 1.1k citations indexed

About

Shigeru Yoshizawa is a scholar working on Rheumatology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Shigeru Yoshizawa has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 7 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Shigeru Yoshizawa's work include Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Shigeru Yoshizawa is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Shigeru Yoshizawa collaborates with scholars based in Japan, United Kingdom and United States. Shigeru Yoshizawa's co-authors include Hirota Fujiki, Takashi Sügimura, Takahiko Horiuchi, Takashi Yoshida, Takuo Okuda, Wayne W. Carmichael, Mitsuru Furusawa, Mariyo F. Watanabe, Masami Suganuma and Kiyonori Kobayashi and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.

In The Last Decade

Shigeru Yoshizawa

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shigeru Yoshizawa Japan	15	311	240	213	184	137	37	1.1k
Jun Yatsunami Japan	19	164 0.5×	519 2.2×	254 1.2×	276 1.5×	82 0.6×	40	1.2k
Klazina S. Bosch Netherlands	20	147 0.5×	324 1.4×	104 0.5×	93 0.5×	188 1.4×	40	1.1k
Keizo Maita United States	17	82 0.3×	218 0.9×	81 0.4×	96 0.5×	32 0.2×	59	907
Richard H. Bruner United States	17	155 0.5×	220 0.9×	54 0.3×	104 0.6×	29 0.2×	24	771
Seiji Yoshizawa Japan	10	107 0.3×	116 0.5×	93 0.4×	30 0.2×	33 0.2×	26	503
Yuan Yao United States	25	69 0.2×	1.7k 7.0×	125 0.6×	307 1.7×	202 1.5×	51	2.5k
Félix V. Vega Spain	17	77 0.2×	488 2.0×	52 0.2×	101 0.5×	95 0.7×	26	1.1k
Noel R. Monks United States	16	93 0.3×	335 1.4×	46 0.2×	217 1.2×	33 0.2×	33	776
F.V. Vega Spain	13	72 0.2×	332 1.4×	32 0.2×	131 0.7×	85 0.6×	26	1.1k

Countries citing papers authored by Shigeru Yoshizawa

Since Specialization

Citations

This map shows the geographic impact of Shigeru Yoshizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Yoshizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Yoshizawa more than expected).

Fields of papers citing papers by Shigeru Yoshizawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Yoshizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Yoshizawa. The network helps show where Shigeru Yoshizawa may publish in the future.

Co-authorship network of co-authors of Shigeru Yoshizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Yoshizawa. A scholar is included among the top collaborators of Shigeru Yoshizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Yoshizawa. Shigeru Yoshizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kiyohara, Chikako, Yasutaka Kimoto, Shuji Nagano, et al.. (2022). Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study. Arthritis Research & Therapy. 24(1). 131–131. 1 indexed citations

Yoshizawa, Shigeru, et al.. (2022). Clinical features of acute exacerbation in rheumatoid arthritis–associated interstitial lung disease: Comparison with idiopathic pulmonary fibrosis. Respiratory Medicine. 200. 106898–106898. 11 indexed citations

Yoshizawa, Shigeru, et al.. (2022). Acute exacerbation in antineutrophil cytoplasmic antibody-associated interstitial lung disease: Clinical features and risk factors. Respiratory Medicine. 203. 106992–106992. 8 indexed citations

Mori, Shunsuke, Tamami Yoshitama, Toshihiko Hidaka, et al.. (2017). Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan. PLoS ONE. 12(6). e0179179–e0179179. 32 indexed citations

Nakashima, Yasuharu, Hisaaki Miyahara, Masakazu Kondo, et al.. (2016). Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses. Modern Rheumatology. 27(1). 15–21. 9 indexed citations

Kimoto, Yasutaka, et al.. (2014). Pleuritis Clinically Diagnosed as Aspergillosis during the Course of Microscopic Polyangiitis. Internal Medicine. 53(24). 2821–2824. 3 indexed citations

Ono, Nobuyuki, Hiroaki Niiro, Akira Ueda, et al.. (2014). Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan. Rheumatology International. 35(3). 555–559. 40 indexed citations

Yoshizawa, Shigeru, Kiyonori Kobayashi, Tomoe Katsumata, Katsunori Saigenji, & Isao Okayasu. (2007). Clinical usefulness of EUS for active ulcerative colitis. Gastrointestinal Endoscopy. 65(2). 253–260. 15 indexed citations

Kobayashi, Kiyonori, Tomoe Katsumata, Shigeru Yoshizawa, et al.. (2005). Indications of Endoscopic Polypectomy for Rectal Carcinoid Tumors and Clinical Usefulness of Endoscopic Ultrasonography. Diseases of the Colon & Rectum. 48(2). 285–291. 101 indexed citations

10.

Kobayashi, Kiyonori, Mitsuhiro Kida, Tomoe Katsumata, et al.. (2004). CLINICAL ROLE OF ENDOSCOPIC ULTRASONOGRAPHY FOR THE DIAGNOSIS OF EARLY COLORECTAL CANCER AND SELECTING THE TREATMENT PROCEDURE. Acta gastro-enterologica belgica. 46(9). 2132–2140. 3 indexed citations

11.

Otsuka, Junji, Takahiko Horiuchi, Shigeru Yoshizawa, et al.. (2004). Association of a four–amino acid residue insertion polymorphism of the HS1 gene with systemic lupus erythematosus: Molecular and functional analysis. Arthritis & Rheumatism. 50(3). 871–881. 14 indexed citations

12.

Kobayashi, Kiyonori, Mitsuhiro Kida, Tomoe Katsumata, et al.. (2003). Clinical role of endoscopic ultrasonography for the diagnosis of early colorectal cancer and selecting the treatment procedure. Digestive Endoscopy. 15(4). 298–305. 13 indexed citations

13.

Kojima, Takeshi, Takahiko Horiuchi, Hiroaki Nishizaka, et al.. (2000). Analysis of Fas ligand gene mutation in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 43(1). 135–139. 19 indexed citations

14.

Higuchi, Masanori, Takahiko Horiuchi, Takuya Sawabe, et al.. (1999). Establishment and Characterization of a Fas-Resistant T Cell Line. Acta Haematologica. 102(1). 22–30. 1 indexed citations

15.

Kanaji, Sachiko, et al.. (1998). Hemophagocytic syndrome associated with fulminant ulcerative colitis and presumed acute pancreatitis. The American Journal of Gastroenterology. 93(10). 1956–1959. 21 indexed citations

16.

Tatematsu, Masae, Jun Yatsunami, Shigeru Yoshizawa, et al.. (1992). An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats. Carcinogenesis. 13(10). 1841–1845. 47 indexed citations

17.

Matsushima, Rie, Shigeru Yoshizawa, Mariyo F. Watanabe, et al.. (1990). and effects of protein phosphatase inhibitors, microcystins and nodularin, on mouse skin and fibroblasts. Biochemical and Biophysical Research Communications. 171(2). 867–874. 172 indexed citations

18.

Fujiki, Hirota, et al.. (1989). Sarcophytols A and B inhibit tumor promotion by teleocidin in two-stage carcinogenesis in mouse skin. Journal of Cancer Research and Clinical Oncology. 115(1). 25–28. 29 indexed citations

19.

Fujiki, Hirota, Masami Suganuma, Shigeru Yoshizawa, et al.. (1989). Codon 61 Mutations in the c‐Harvey‐ras Gene in Mouse Skin Tumors Induced by 7,12‐Dimethylbenz[a]anthracene Plus Okadaic Acid Class Tumor Promoters. Molecular Carcinogenesis. 2(4). 184–187. 48 indexed citations

20.

Fujiki, Hirota, Masami Suganuma, Hiroko Suguri, et al.. (1988). Diarrhetic Shellfish Toxin, Dinophysistoxin‐1, Is a Potent Tumor Promoter on Mouse Skin. Japanese Journal of Cancer Research. 79(10). 1089–1093. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact